In a groundbreaking advancement in the treatment of metastatic urothelial cancer, a recent clinical trial has explored the synergistic potential of combining immune checkpoint inhibitors tremelimumab and durvalumab with the chemotherapeutic agent paclitaxel. This phase I/II ICRA trial, published in the prestigious Nature Communications, offers compelling evidence that dual immune modulation with or without chemotherapy may redefine therapeutic paradigms for this challenging malignancy. The innovative study meticulously investigates the safety profile, optimal dosing, and preliminary efficacy signals of these agents when administered simultaneously, charting a promising new course in oncologic therapeutics.

Urothelial carcinoma, predominantly affecting the bladder, represents a formidable oncological challenge due to its aggressive nature and propensity for metastasis upon progression. While immune checkpoint inhibitors have revolutionized cancer care by unleashing the host’s immune system against tumor cells, their efficacy as monotherapy in advanced urothelial cancer remains variable. Tremelimumab, a monoclonal antibody targeting CTLA-4, and durvalumab, an anti-PD-L1 antibody, function by disrupting distinct immunosuppressive pathways that tumors exploit to evade immune detection. The rationale behind combining these agents with paclitaxel—a cytotoxic drug known for interfering with microtubule dynamics—lies in the complementary mechanisms that might potentiate antitumor responses.

The trial enrolled patients with histologically confirmed metastatic urothelial cancer who had exhausted or were ineligible for standard therapeutic options. Participants received varying regimens comprising tremelimumab alone, tremelimumab plus durvalumab, and either combination with paclitaxel. This design sought to delineate the safety thresholds and dose-limiting toxicities while enabling exploratory analyses of clinical outcomes such as progression-free survival and objective response rates. Detailed immune profiling and biomarker assessments accompanied the clinical evaluations to decipher correlates of response and resistance.

Initial data reveal that the combination treatments are generally well tolerated, with adverse events consistent with known profiles of checkpoint inhibitors and chemotherapy. Immune-related adverse events—such as dermatitis, colitis, and endocrinopathies—were manageable within established guidelines, emphasizing the importance of vigilant monitoring and timely intervention. Importantly, no unexpected synergistic toxicities emerged, suggesting that these agents can be safely coadministered without exacerbating systemic toxicity.

From an efficacy standpoint, tremelimumab combined with durvalumab and paclitaxel demonstrated encouraging antitumor activity, surpassing response rates historically observed with any single agent in this patient cohort. Objective responses included significant tumor burden reductions, with some patients experiencing durable disease stabilization or partial remission. Notably, the addition of paclitaxel appeared to enhance immunogenic cell death, potentially promoting antigen presentation and T-cell activation, thus amplifying the therapeutic window of the checkpoint blockade.

Correlative translational studies provided insights into the immunological milieu shaping treatment responses. Tumor biopsies and peripheral blood analyses highlighted increased infiltration of CD8+ cytotoxic T lymphocytes and a concomitant decrease in immunosuppressive regulatory T cells in responders. Furthermore, upregulation of interferon-gamma signaling pathways and enhanced expression of antigen processing machinery were observed, aligning with the hypothesis that chemotherapy-induced immunogenicity synergizes with checkpoint inhibition to invigorate antitumor immunity.

Another pivotal observation was the heterogeneity in patient outcomes, underscoring the necessity for biomarker-driven patient stratification. Molecular profiling identified tumor mutational burden and PD-L1 expression levels as potential predictive biomarkers, although their roles require further validation. Intriguingly, emerging evidence suggests that tumor microenvironment features—such as cytokine profiles and myeloid cell populations—may also influence responsiveness, opening new avenues for personalized immunotherapy approaches.

The trial’s phased escalation design allowed for adaptive modifications based on interim results, optimizing dosing regimens to balance efficacy and safety. These methodological strengths enhance the reliability of conclusions drawn and set a precedent for future combination trials in urothelial carcinoma and beyond. Additionally, pharmacokinetic analyses confirmed that neither agent significantly altered the metabolism of the others, supporting their compatibility in combination therapies.

This landmark investigation contributes critical knowledge to the evolving landscape of bladder cancer treatment by demonstrating how rationally designed combinations of immune checkpoint inhibitors and chemotherapies can elicit potent antitumor effects in metastatic disease. Given the historically poor prognosis for advanced urothelial cancer, these findings herald a new era where multi-agent immunomodulation may offer renewed hope for patients. However, broader phase III studies will be essential to confirm survival benefits and thoroughly characterize long-term safety.

Moreover, the translational components embedded within this study exemplify the growing trend towards integrating laboratory science with clinical oncology. Such integrative approaches are crucial for unraveling the complex interplay between tumor biology and therapeutic interventions, ultimately facilitating the development of more effective, tailored treatments. The ICRA trial represents an exemplar of precision medicine in action, advancing beyond one-size-fits-all approaches towards nuanced, biomarker-informed strategies.

While the current research focuses on metastatic urothelial carcinoma, the implications extend to other malignancies where immune evasion is a critical obstacle. The dual blockade of CTLA-4 and PD-L1 pathways in concert with chemotherapeutic agents may prove universally applicable, prompting parallel investigations across diverse cancer types. Furthermore, understanding the mechanisms that underlie response and resistance could inform the design of next-generation immunotherapies, including combination regimens incorporating novel agents such as oncolytic viruses, vaccines, or cell-based therapies.

In the broader context of cancer immunotherapy, the trial reinforces the concept that combining immune checkpoint inhibitors with traditional cytotoxic chemotherapy can create a more hostile environment for cancer cells while simultaneously activating immune effector functions. This synergistic interaction leverages the strengths of both modalities: chemotherapy disrupts tumor cell replication and induces immunogenic cell death, while checkpoint inhibitors relieve inhibitory signals that dampen T-cell activity. Together, they orchestrate a multifaceted assault on cancer.

The success of this approach depends heavily on careful patient selection, vigilant management of immune-related adverse events, and comprehensive biomarker development. As immune therapies increasingly become standard in oncology, multidisciplinary collaborations between clinicians, immunologists, and computational biologists will be vital to fully harness their potential. The ICRA trial epitomizes such collaborative effort, merging clinical expertise with cutting-edge immunological research.

In summary, the phase I/II ICRA trial investigating tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer delineates a compelling therapeutic strategy blending checkpoint blockade and chemotherapy. It underscores important principles regarding safety, efficacy, and mechanistic synergy while illuminating paths for future exploration. As the oncology community eagerly awaits results from larger confirmatory studies, this trial stands as a milestone in the continuous quest to improve outcomes for patients facing this formidable disease.

---

Subject of Research: Combination immunotherapy with tremelimumab and durvalumab alongside paclitaxel chemotherapy in metastatic urothelial cancer.

Article Title: Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

Article References: Einerhand, S.M.H., Ali, H., Wong, S.Q. et al. Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial. Nat Commun (2026). https://doi.org/10.1038/s41467-026-74570-3

Image Credits: AI Generated

No todos los materiales valiosos brillan ni se guardan en bóvedas. Algunos existen en minas remotas, reactores nucleares o aceleradores de partículas, y su precio depende tanto de su rareza como de lo difícil que resulta producirlos, aislarlos o mantenerlos estables. La antimateria sigue siendo el caso más extremo: CERN recuerda que solo puede producirse y almacenarse en cantidades minúsculas, mientras que el californio-252 se usa como potente fuente de neutrones en aplicaciones nucleares e industriales.

Researchers have captured the first atomic-level views of human SMUG1, a key enzyme involved in repairing damaged DNA. Every cell in your body is constantly battling damage to its DNA. Now, scientists have captured the first atomic level images of a key human repair enzyme in action, revealing how cells identify and remove some of [...]

Relativity Space plans to launch a Mars orbiter in 2028 as part of a new initiative to privately develop planetary missions.

The post Relativity Space to privately develop Mars orbiter mission appeared first on SpaceNews.

The former Sequoia Capital leader is filling an "existing vacancy" on SpaceX's board, days after the company went public in the largest IPO ever.

The preliminary U.S.-Iran deal temporarily waives restrictions that have limited the country’s oil sales and how much money it has been able to make from those exports.

© Atta Kenare/Agence France-Presse — Getty Images

Un ensayo del programa POWER de DARPA logró entregar más de 800 vatios durante 30 segundos a un receptor situado a 8,6 kilómetros del emisor láser. La prueba, realizada en Nuevo México, forma parte de una idea ambiciosa: crear redes capaces de enviar energía a distancia hacia zonas remotas, vehículos, drones o escenarios donde transportar combustible resulta lento, caro o peligroso.

In recent years, the coastal waters of Vancouver have witnessed an unprecedented resurgence of whale activity, captivating marine biologists and local observers alike. This renewed presence, not merely anecdotal, stems from a culmination of seasonal patterns, thriving ecosystems, and impactful conservation measures. A comprehensive study led by researchers at the University of British Columbia’s Institute for the Oceans and Fisheries (IOF) has quantitatively confirmed that transient killer whales now inhabit the Salish Sea for more than two-thirds of the year. Alongside these apex predators, humpback and grey whales are increasingly frequenting these waters, signaling a dynamic shift in regional marine biodiversity.

Transient killer whales, known for their elusive nature and specialized diet of marine mammals, particularly seals and sea lions, are now commonly sighted along Vancouver’s shoreline and within the surrounding straits and harbors. Data collected from 2016 to 2023 underscores not only their presence but also their routine exploitation of these rich feeding grounds. This expanded usage correlates strongly with the rebound of pinniped populations, themselves benefiting from decades-old protections that halted their severe culling. The recovery has thus created a robust trophic cascade, enabling transient killer whales to establish a near year-round residency within the inside waters of Vancouver Island.

Humpback whales represent another remarkable comeback story in this region. Historically decimated by intense commercial whaling in the early 20th century, these baleen giants were completely extirpated from British Columbia waters by 1910. Without older generations to transmit migratory and feeding knowledge, their return to ancestral feeding grounds was lost for nearly a century. However, conservation efforts since the 1960s, including international bans on whaling and improved fisheries management, have facilitated a population recovery that now sees substantial numbers of humpbacks returning each summer to feast on abundant krill, herring, and other prey.

The presence of grey whales in areas around Vancouver is comparatively anomalous but increasingly documented. These whales typically forage offshore near Alaska, subsisting on amphipods—small crustaceans dependent on nutrient-rich algae associated with Arctic sea ice. The drastic loss of sea ice due to climate change directly undermines this fundamental food source, causing nutritional stress especially among pregnant and lactating females who must meet extraordinarily high energetic demands during migration and calf-rearing periods. Consequently, some grey whales are observed making unscheduled stops in the Salish Sea, an adaptation that reflects their deteriorating foraging options rather than traditional migratory behavior.

Studies estimate that pregnant grey whales require a daily intake of approximately 1,600 to 1,900 kilograms of prey to sustain both fetal development and energy reserves critical for postnatal care during their long migrations. Following calving, lactating females continue to consume between 1,300 and 1,600 kilograms of prey daily to nourish their calves for several months. Disruptions in prey availability, driven by climate-induced changes in sea ice and associated ecosystem dynamics, are thus placing immense physiological strain on these populations. The unfortunate consequence has been an observed increase in mortality rates, with malnourished grey whales occasionally stranding along the coastline.

This resurgence of whale activity near Vancouver not only highlights the success of targeted conservation policies but also underscores emerging challenges. Increased interactions between humans and whales necessitate rigorous adherence to safe viewing practices. Researchers advocate for maintaining substantial distances from whales—minimum thresholds are typically 200 meters for most killer whales and extend to 1,000 meters for the endangered southern resident killer whales. The regulations also stipulate 100 meters for other cetaceans, increasing to 200 meters when whales are resting or accompanied by calves. These guidelines are critical in minimizing disturbances and preventing collisions, which pose significant risks to these vulnerable animals.

Furthermore, the role of public awareness and responsible recreational boating cannot be overstated. Boaters, kayakers, and paddleboarders are urged to stay vigilant and reduce speeds when whale blowholes are sighted. The unpredictability of whale movements demands a precautionary approach to navigation within whale habitats. Educational initiatives, such as free online whale-safe boating courses offered by organizations like the Marine Education & Research Society (MERS), have proven effective tools in promoting safer human-wildlife coexistence in marine environments.

The broader implications of these findings extend into the realm of ecosystem health and global climate resilience. Whales function as keystone species, their feeding and migratory behaviors facilitating nutrient transport and productivity within marine systems. The return of diverse whale populations to coastal waters symbolizes not just ecological recovery but offers hope for restoring complex marine food webs fractured by human exploitation. Yet, the acute vulnerability of species such as grey whales to climate-driven habitat changes serves as a stark reminder of ongoing environmental threats.

Simultaneously, the study’s revelations about transient killer whales reveal a nuanced predator-prey dynamic finely attuned to regional ecosystem changes over recent decades. The resurgence of pinniped populations has provided these cetaceans with ample sustenance, allowing for sustained presence in traditionally seasonal zones. This trophic realignment invites further studies into the long-term evolutionary and behavioral adaptations of marine mammals in a rapidly changing oceanic milieu.

Whale conservation is, thus, at a critical juncture. While success stories abound, exemplified by humpback recovery, emerging stressors including climate change, ship traffic, and underwater noise pollution complicate the ecological narrative. The scientific community and policymakers must continue fostering adaptive management strategies that address these multifaceted challenges while engaging public participation for effective stewardship.

In conclusion, the intensifying presence of transient killer whales, humpbacks, and grey whales in Vancouver’s coastal waters offers a vivid testament to both nature’s resilience and the pressing need for sustained conservation vigilance. These marine mammals, emblematic of wider ocean health, depend on intact habitats, thoughtful human behaviors, and responsive environmental policies. As our understanding deepens through ongoing research, so too must our commitment to coexistence with these ocean giants, ensuring their survival amidst an era of rapid ecological transformation.

---

Subject of Research: Marine mammal population dynamics and conservation in Pacific Northwest coastal waters.

Article Title: Rebounding Giants: The Return of Whales to Vancouver’s Coastal Waters

News Publication Date: Not specified in the provided content.

Web References:

• https://onlinelibrary.wiley.com/doi/epdf/10.1111/mms.70205
• https://onlinelibrary.wiley.com/doi/10.1111/mms.70119
• https://courses.mersociety.org/courses/whale-safe-boating

References:

• Taryn Scarff et al., “Transient killer whales in the Salish Sea,” Marine Mammal Science
• Grey whale energetics and climate impact study, Marine Mammal Science

Image Credits: Julia Adelsheim

Keywords: Whales, Cetaceans, Marine mammals, Transient killer whales, Humpback whales, Grey whales, Conservation, Climate change effects, Salish Sea, Marine ecology, Pinnipeds, Fisheries management

A groundbreaking hospital-based study conducted in India sheds new light on the complex and often controversial relationship between lifestyle factors and prostate cancer risk. Published in the April 28, 2026 issue of Oncoscience, this investigation provides intriguing evidence that certain modifiable habits, specifically coffee and meat consumption, may significantly reduce the likelihood of developing prostate cancer among men. This revelation emerges despite prostate cancer being the world’s second most prevalent malignancy in men and a critical contributor to cancer-related mortality.

The research was spearheaded by Maya Kulshekar and Anuradha B. Patil at the Department of Biochemistry, Jawaharlal Nehru Medical College, part of the KLE Academy of Higher Education and Research in Karnataka, India. Their work comes at a crucial moment when the incidence of prostate cancer in India is poised to rise markedly, underscoring the urgent need to identify interventions grounded in modifiable risk behaviors.

In this rigorously designed study, 72 men with histopathologically confirmed prostate cancer were compared to 132 control individuals diagnosed with benign prostatic hyperplasia (BPH). The investigators carefully examined a suite of lifestyle factors—ranging from tobacco use and alcohol consumption to dietary patterns including tea, coffee, and meat intake, as well as occupational exposure linked to farming. Thorough multivariate logistic regression analyses allowed the team to adjust for confounding variables, thereby refining the associations between these factors and prostate cancer risk.

The findings revealed a striking inverse association between coffee consumption and prostate cancer risk, translating to an approximate 65% reduction in odds after adjustment for potential confounders. Meat consumption similarly demonstrated a protective effect, associated with a roughly 48% decreased risk. These results challenge some conventional nutritional beliefs and highlight the nuanced role diet may play in modulating prostate oncogenesis.

Contrastingly, the study found no statistically significant correlation between alcohol consumption, tobacco chewing, smoking, tea intake, or farming-related occupational exposure and prostate cancer once confounding factors were accounted for. Initial univariate analyses suggested elevated risk linked to smoking and tobacco chewing; however, these associations dissipated under multivariable scrutiny, suggesting the potential influence of other interacting factors.

The biochemical mechanisms underpinning these associations were thoughtfully explored by the authors. Coffee is a complex beverage rich in bioactive compounds including caffeine, cafestol, kahweol, and a spectrum of antioxidant polyphenols. These molecules have been extensively studied for their anti-inflammatory and antioxidant properties, implicating them in pathways that may suppress malignant transformation or tumor progression. Their capacity to modulate cellular stress responses, DNA repair, and immune regulation positions coffee as a potent functional food in cancer prevention paradigms.

Similarly, meat contains constituents such as trans-vaccenic acid, an unsaturated fatty acid that has been observed in some experimental models to influence immune responses and cellular signaling pathways relevant to oncogenesis. Notwithstanding, the study authors caution that the protective role of meat is complicated by the heterogeneity inherent in types of meat, cooking methods, and quantity consumed—parameters that were not stratified in this investigation. The metabolic and molecular consequences of processed versus unprocessed meats or the generation of carcinogenic compounds during certain cooking processes remain pivotal confounders warranting further rigorous examination.

This research importantly acknowledges the broader scientific context where prior epidemiological studies have reported inconsistent and at times contradictory findings regarding coffee, meat, tobacco, tea, and alcohol in relation to prostate cancer risk. This inconsistency may stem from differences in study design, dietary assessment methods, population genetics, and environmental factors across cohorts. The current study’s contribution lies in focusing on an Indian population, thereby addressing a geographic and ethnic gap in the literature.

The methodological design, while robust, is not without limitations. The single-center hospital-based sample, and relatively modest cohort size, may affect the generalizability of the findings. Additionally, potential recall bias in self-reported lifestyle habits and the absence of quantitative dietary intake measures restrict the granularity of exposure assessment. The authors advocate for larger, multicenter, and longitudinal studies with comprehensive dietary and lifestyle quantification to validate and expand upon these preliminary observations.

This investigation marks an important step toward understanding how modifiable lifestyle factors could temper the risk of prostate cancer. By highlighting coffee and meat intake as potentially protective, the study invites a reevaluation of dietary guidelines and preventive oncology strategies within the Indian context and beyond. The mechanistic insights further fuel the search for bioactive compounds that could be leveraged in therapeutic or nutraceutical formulations.

Ultimately, these findings reinforce the imperative for personalized medicine approaches that integrate lifestyle, genetic, and environmental data to optimize cancer prevention and management. They also echo broader calls within the oncological community to pursue open-access, multidisciplinary research that bridges molecular science with public health imperatives.

While the findings demand cautious interpretation, they open an exciting avenue for leveraging everyday dietary choices as part of a comprehensive prostate cancer risk reduction strategy. As prostate cancer incidence is projected to escalate, especially in rapidly modernizing societies, these insights provide a timely beacon for clinicians, researchers, and policy makers alike.

The study’s implications extend beyond prostate cancer, emphasizing a holistic perspective on how complex interplays of diet, lifestyle, and biological mechanisms coalesce to impact carcinogenesis. It epitomizes the potential for traditional epidemiological research, augmented by advanced statistical modeling, to generate actionable knowledge that may ultimately improve patient outcomes on a population scale.

Researchers and clinicians interested in this expanding field are encouraged to follow ongoing and future work from this team and related cohorts worldwide, as the quest to decipher modifiable risk factors of prostate cancer continues to gain precision and impact.

---

Subject of Research: People
Article Title: Modifiable risk factors of prostate cancer: Insights from a hospital-based study
News Publication Date: 28-Apr-2026
Web References: https://doi.org/10.18632/oncoscience.657
Image Credits: Copyright © 2026 Kulshekar et al. Creative Commons Attribution License (CC BY 4.0)
Keywords: modifiable risk factors, prostate cancer, awareness, India, molecular mechanism

A peregrine falcon in a hunting dive reaches a terminal velocity of about 320 km/h (200 mph), which makes it the fastest animal alive.

That figure is not a guess from a single enthusiast with a stopwatch. A peer-reviewed aerodynamics study notes that peregrines exceed 320 km/h in a full stoop, though its own filmed dives took place past a 60 m dam — short enough that the falcons never reached terminal velocity, but long enough to capture the changing wing shape on high-speed cameras. The record claim sits higher still: a captive falcon named Frightful was reportedly clocked at 389 km/h (242 mph) in 1999 after release from a light aircraft.

For comparison, the Guinness World for the fastest speed in an Formula 1 car is 372.56 km/h (231.51mph). These cars need a long straight and lots of horsepower. The falcon gets there with body mass, gravity, and a folded silhouette, then has to land a precise strike at the end of it. The car only has to keep going straight.

The dive has a name: the stoop. The record speed belongs only to the dive, and the dive depends on shape. Robin Mills, a biologist who has modelled the manoeuvre, describes it this way: “Within the blink of an eye, it dives down – first flapping forcefully and then folding its wings to decrease drag. It basically appears to drop out of the sky.” All of this is in service of the strike at the bottom — the stoop is how the falcon turns altitude into a killing blow.

The peregrine delivers the blow with its feet, used as a blunt weapon rather than as the gripping talons most people picture. The popular image of a clenched fist is roughly right but not exact. The Birds of Stanford essays note that “High-speed cinematographic studies, however, have shown that they strike their prey from above with all four toes fully extended.” The foot may be open at the instant of contact, not closed, though the strike itself remains a percussive hit rather than a grab.

The impact does much of the killing. Peregrines and their close relatives carry only modest talons, so they cannot rely on the crushing grip that some larger raptors use. Instead, as Fowler and colleagues describe in their study of raptor anatomy, “For immobilisation, Falconini rely more strongly on strike impact and breaking the necks of their prey, having evolved a ‘tooth’ on the beak to aid in doing so.” The dive does the work, and the notched beak finishes what the blow starts.

The speed record hides something. A car at 320 km/h is being asked to follow a known line on a known surface. The falcon is being asked to intercept a small, frightened, swerving target in open air, and to do it while its own anatomy works against it. The peregrine’s sharpest vision sits off to the side of its eye, not straight ahead. Tucker and colleagues put the problem plainly: “When diving at prey straight ahead from great distances at high speeds, a peregrine has a conflict between vision and aerodynamics.”

To see the prey clearly, the bird “must turn its head approximately 40 ° to one side” to fix the target on the most acute part of its eye, but a turned head adds drag and slows the dive. Wild peregrines solve this not by turning the head but by curving the whole approach. Tucker’s team observed birds tracking distant prey along a curved path resembling a logarithmic spiral, which keeps the target pinned on that sideways high-acuity vision while the head stays streamlined. It is the aerial equivalent of taking the racing line rather than the shortest one.

The precision goes deeper than the path. A 2018 simulation by Mills and colleagues at Groningen and Oxford modelled the attack and found the diving falcon steers using the same proportional-navigation logic that guides missiles. The same work is careful about what high speed actually buys. The simulations suggest that when prey moves erratically, high-altitude stoops raise catch success compared with low-altitude attacks, but only if the falcon’s guidance law is finely tuned and its vision and control are precise. Speed without that control is just a fast miss. This is a modelling result rather than a field measurement, so it is best read as a clue to how the real birds manage it, not the last word.

The body comes equipped for the rest. Bony tubercles inside the nostrils are thought to limit the air rushing in at speed, and a translucent third eyelid sweeps across the eye to protect it while still letting the falcon see, a built-in visor for a pilot who cannot afford to blink at the wrong moment.

The post In a hunting dive, the peregrine falcon becomes the fastest animal alive, plunging at speeds of more than 320 km/h — before striking its prey in mid-air, a blow that can kill on impact appeared first on Space Daily.

La mejor forma de encontrar tecnofirmas es buscando las que han sobrevivido durante más tiempo a sus creadores, según afirman en un trabajo de investigación.

JCMT0402-0424, a dusty starburst galaxy around 11 billion light-years away, is the strongest candidate yet for the source of the high-energy neutrino event IC 210922A, according to a team of astronomer led by Yuji Urata of MITOS Science Co.

The post Astronomers Trace Elusive High-Energy Neutrino to Star-Forming Galaxy in Early Universe appeared first on Sci.News: Breaking Science News.

Un trabajo publicado analizó bases de datos volcánicas, modelos tomográficos y simulaciones del flujo del manto para rastrear la relación entre grandes erupciones y estructuras profundas de la Tierra. El resultado apunta a que muchas de estas erupciones están vinculadas con plumas del manto que ascienden desde enormes regiones calientes situadas cerca de la base del planeta.

What happens when you give AI coding agents a lab full of robotic arms, some compute resources, and a “generous token budget” for teaching the robots various tasks? The agents can apparently figure out a training regimen that teaches the robots to successfully cut zip ties and even insert GPUs into thin sockets on motherboards.

That glimpse into how AI can act in a fully autonomous way to automate robot training was made possible by a new agent harness framework—software that wraps around AI models to enable their use of various tools while also providing capabilities such as memory, context, constraint, and feedback loops. That agentic harness, called ENPIRE, was developed by robotics researchers at the Nvidia GEAR (Generalist Embodied Agent Research) lab alongside collaborators from Carnegie Mellon University in Pittsburgh and the University of California, Berkeley.

“A part of our NVIDIA GEAR lab now self-improves tirelessly overnight,” wrote Jim Fan, director of AI at NVIDIA, in a LinkedIn post. “We just read the reports in the morning.”

Read full article

Comments

© NVIDIA

An Ariane 6 with upgraded solid rocket boosters successfully launched three dozen Amazon Leo satellites June 17 as ESA weighs options for increasing the vehicle’s launch rate.

The post Upgraded Ariane 6 launches Amazon Leo satellites appeared first on SpaceNews.

Une anomalie au cœur de la Voie lactée intrigue les astronomes depuis des décennies. Et les dernières observations du télescope spatial James-Webb viennent de transformer une curiosité en véritable casse-tête cosmique. De quoi changer notre vision de la formation des galaxies.

Un estudio publicado en Nature Geoscience describe pulsos rítmicos de roca caliente ascendiendo desde el manto bajo la región de Afar, en Etiopía. Estos movimientos profundos no parten África de golpe, pero ayudan a estirar y adelgazar la corteza en una de las zonas tectónicas más activas del planeta, donde algún día podría abrirse una nueva cuenca oceánica.

A US filing says Grok was used in military operations tied to Iran, surfacing through an environmental lawsuit over xAI gas turbines.

Using NASA’s Goldstone Solar System Radar and NSF’s Green Bank Telescope, astronomers from the University of California, Los Angeles, confirmed that the icy surface of Jupiter’s moon Europa scatters radio energy in an unusually strong and complex way not seen on rocky worlds.

The post Radar Observations Reveal New Clues about Europa’s Hidden Interior appeared first on Sci.News: Breaking Science News.

Researchers at Washington University School of Medicine in St. Louis have made a groundbreaking discovery that could revolutionize the prevention of diarrheal diseases caused by enterotoxigenic Escherichia coli (ETEC) and Shigella. These two bacterial pathogens are responsible for hundreds of millions of infections annually and are leading causes of diarrheal mortality worldwide, particularly among young children. Despite decades of efforts, vaccine development has encountered significant obstacles, primarily due to the extensive strain variability that hampers the identification of universal vaccine targets.

In a recent study published in the Proceedings of the National Academy of Sciences, the WashU team, collaborating with scientists at the University of Missouri and the International Centre for Diarrhoeal Disease Research in Bangladesh, identified a shared vulnerability within these pathogens that could open the door for a combined vaccine platform. This innovative approach hinges on targeting homologous enzymes that these bacteria use to degrade the mucus lining in the human gut, a critical step in establishing infection.

For bacterial pathogens like ETEC and Shigella to cause illness, they first need to overcome the intestinal mucus barrier. This thick layer of mucus serves as a physical and biochemical shield protecting the gut epithelium and regulating the microenvironment by keeping pathogenic entities at bay while preserving the beneficial microbiota. The ability to breach this barrier is a hallmark of pathogenicity, allowing bacteria to access the underlying tissues and deploy additional virulence factors, including enterotoxins that induce diarrhea.

The study’s focal point is a family of mucin-degrading enzymes that facilitate this breaching process. The researchers detail three closely related enzymes—EatA, SepA, and Pic—that are expressed by ETEC, Shigella, and other diarrheal pathogens. EatA, an acronym for “eat away,” is produced by ETEC and was previously identified by Fleckenstein’s laboratory as a critical mucinase targeting the primary structural protein within mucus. SepA and Pic, related enzymes produced by Shigella and some other bacteria, perform analogous roles. Their enzymatic activity effectively dismantles the mucosal barrier, clearing a path for bacterial invasion.

Intriguingly, the antibodies that the team isolated from individuals infected with ETEC or experimentally exposed to the bacteria displayed a functional cross-reactivity. The antibodies not only neutralized EatA but also inhibited SepA and Pic, indicating a conserved epitope region among these mucinases. This neutralization prevents the enzymes from degrading intestinal mucus, thereby blocking the pathogens’ entry into host tissues. The concept of a single antibody interfering with multiple bacterial targets underscores a significant breakthrough in vaccine strategy.

To unravel the structural mechanics behind this immune neutralization, the researchers leveraged cryo-electron microscopy—a state-of-the-art imaging method that preserves biomolecules in near-native states by flash-freezing samples. This technique enabled detailed visualization at atomic resolution, revealing the precise binding site of the neutralizing antibodies. Remarkably, the site of interaction was a structurally conserved region across EatA, SepA, and Pic, providing a rational basis for the design of vaccine antigens that elicit broadly neutralizing antibodies.

“The identification of this shared Achilles’ heel among diverse diarrhea-causing bacteria signifies a paradigm shift in vaccine development,” explains James M. Fleckenstein, MD, co-senior author of the study and professor of medicine at WashU. “It suggests we can target a common mechanism of gut colonization rather than chasing highly variable surface molecules, which has been the stumbling block in the field for so long.”

Further bolstering the translational potential of these findings, epidemiological data from children in Dhaka, Bangladesh, indicate that naturally acquired antibodies against EatA correlate with protection from diarrheal illness. This natural immunity validates EatA as a viable immunological target and encourages the pursuit of vaccines that induce similar protective responses.

The implications extend beyond the developing world, as enterotoxigenic E. coli has been implicated in recent foodborne outbreaks in industrialized countries such as the United States. The difficulty in distinguishing pathogenic ETEC from non-pathogenic strains in clinical settings further complicates diagnosis and containment. Moreover, reliance on antibiotics to treat infections caused by these bacteria accelerates the evolution of antibiotic resistance, posing a global public health threat.

Zachary Berndsen, PhD, assistant professor of biochemistry at the University of Missouri and co-senior author, emphasizes the rational approach to vaccine design enabled by these insights. “By pinpointing enzyme domains targeted by neutralizing antibodies, we provide a template for crafting precise immunogens that can stimulate protective immunity across multiple pathogens. This can streamline the production of vaccines that are both effective and broad-spectrum,” Berndsen says.

Development of such a vaccine could not only reduce the global burden of diarrheal diseases but also mitigate the spread of antibiotic resistance by decreasing the frequency of bacterial infections requiring treatment. Additionally, preserving the gut microbiota through targeted disruption of pathogenic mechanisms may alleviate some adverse consequences associated with broad-spectrum antibiotic use.

Going forward, the research team is focused on translating their molecular discoveries into practical vaccine candidates. This involves preclinical testing of immunogens incorporating the conserved epitopes identified, assessing their immunogenicity and protective efficacy in animal models, and progressing toward human clinical trials.

“In our ongoing battle with enteric pathogens that have coevolved with humans for millennia, blocking the enzymatic opening of the mucus gate represents a promising strategy,” Fleckenstein concludes. “If successful, this vaccine would preempt infection at its earliest and most vulnerable stage, changing the trajectory of diarrheal disease worldwide.”

The study was supported by grants from the National Institute of Allergy and Infectious Diseases and the Department of Veterans Affairs. The multidisciplinary collaboration brings together expertise in infectious diseases, structural biology, immunology, and clinical research, underscoring the necessity of integrated approaches to tackle complex global health challenges.

---

Subject of Research: Human tissue samples

Article Title: Human enterotoxigenic Escherichia coli (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic Escherichia coli and Shigella

News Publication Date: 15-Jun-2026

References:
Buckley DP, Akhtar M, Thapa M, Schmitz A, Turner J, Vickers TJ, Khatoon N, Kaisar MH, Coggin JA, Ganguli D, Sheikh A, Laird RM, Poly F, Porter CK, Ruiz-Perez F, Miller MJ, Chowdhury F, Bhuiyan TR, Qadri F, Trillo-Muyo S, Dolan B, van der Post S, Ellebedy A, Berndsen ZT, Fleckenstein JM. Human enterotoxigenic Escherichia coli (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic Escherichia coli and Shigella. PNAS. June 15, 2026.

Image Credits: David Hasty

Keywords: Infectious diseases, Microbial infections, Diarrhea